| 251 |
19556972 | Aliskiren monotherapy results in the greatest and the least blood pressure lowering in patients with high- and low-baseline PRA levels, respectively. | 2009 Sep |
2 |
| 252 |
19564544 | Cardiac Renin levels are not influenced by the amount of resident mast cells. | 2009 Aug |
1 |
| 253 |
19570132 | Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment. | 2009 Sep |
3 |
| 254 |
19615901 | The P1N-isopropyl motif bearing hydroxyethylene dipeptide isostere analogues of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin. | 2009 Aug 15 |
1 |
| 255 |
19617273 | Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension. | 2009 Dec |
3 |
| 256 |
19649581 | Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension. | 2009 Jul |
2 |
| 257 |
19706425 | Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. | 2009 Sep 1 |
1 |
| 258 |
19707255 | Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors. | 2009 Jun |
1 |
| 259 |
19715410 | Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease. | 2009 Sep |
1 |
| 260 |
19754387 | Prevention of atherosclerosis by interference with the vascular nitric oxide system. | 2009 |
1 |
| 261 |
19762496 | Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria. | 2009 Oct |
1 |
| 262 |
19778947 | Dynamic observation of mechanically-injured mouse femoral artery reveals an antiinflammatory effect of renin inhibitor. | 2009 Nov |
1 |
| 263 |
19786360 | Optimal nephroprotection: use, misuse and misconceptions about blockade of the renin-angiotensin system. Lessons from the ONTARGET and other recent trials. | 2009 Dec |
1 |
| 264 |
19895758 | Direct renin inhibition: an update. | 2009 Dec |
2 |
| 265 |
19900020 | Recent changes in the landscape of combination RAS blockade. | 2009 Nov |
1 |
| 266 |
20019471 | [What is renin inhibition? Mechanism of action]. | 2009 Oct |
3 |
| 267 |
20019473 | [Renin and the heart]. | 2009 Oct |
2 |
| 268 |
20019474 | [Renin inhibition and the kidney]. | 2009 Oct |
2 |
| 269 |
20019475 | [The future of renin inhibition]. | 2009 Oct |
3 |
| 270 |
20019651 | Rational of the use of aliskiren in hypertension and beyond. | 2009 Dec |
2 |
| 271 |
20028326 | Clinical trials of the past decade in the management of chronic kidney disease. | 2009 Sep |
1 |
| 272 |
20046162 | Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity. | 2009 Dec |
3 |
| 273 |
20069969 | [Advances concerning aliskiren, direct renin inhibitor and aliskiren-hydrochlorothiazide]. | 2009 Nov |
2 |
| 274 |
20329413 | Renin inhibition--benefit beyond hypertension control. | 2009 Jul |
1 |
| 275 |
20380117 | Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade? | 2009 |
3 |
| 276 |
20409974 | Renal plasma flow: glomerular filtration rate relationships in man during direct renin inhibition with aliskiren. | 2009 Sep-Oct |
1 |
| 277 |
18160962 | Antihypertensive therapy with aliskiren. | 2008 Mar |
2 |
| 278 |
18216149 | Activation of a local renin angiotensin system in podocytes by glucose. | 2008 Apr |
1 |
| 279 |
18234150 | A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with allopurinol, celecoxib and cimetidine in healthy subjects. | 2008 Mar |
1 |
| 280 |
18237679 | Renin inhibition in hypertension. | 2008 Feb 5 |
3 |
| 281 |
18273042 | Effects of aliskiren, a renin inhibitor, on biomarkers of platelet activity, coagulation and fibrinolysis in subjects with multiple risk factors for vascular disease. | 2008 May |
2 |
| 282 |
18288088 | Pharmacokinetic/pharmacodynamic modeling of renin biomarkers in subjects treated with the renin inhibitor aliskiren. | 2008 Jul |
3 |
| 283 |
18307734 | Renin inhibition with aliskiren. | 2008 Apr |
3 |
| 284 |
18308634 | Current concepts: renin inhibition in the treatment of hypertension. | 2008 Apr |
3 |
| 285 |
18327992 | Aliskiren-hydrochlorothiazide combination for the treatment of hypertension. | 2008 Mar |
2 |
| 286 |
18335187 | PLZF and the (pro)renin receptor. | 2008 Jun |
2 |
| 287 |
18337712 | Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes. | 2008 Jun |
1 |
| 288 |
18340340 | Aliskiren: the first renin inhibitor for clinical treatment. | 2008 May |
2 |
| 289 |
18343241 | Aliskiren: renin inhibitor for hypertension management. | 2008 Jan |
2 |
| 290 |
18345958 | Aliskiren: clinical experience and future perspectives of renin inhibition. | 2008 Apr |
2 |
| 291 |
18368379 | Direct renin inhibition: clinical pharmacology. | 2008 Jun |
3 |
| 292 |
18374681 | Oral direct renin inhibition: premise, promise, and potential limitations of a new antihypertensive drug. | 2008 Apr |
2 |
| 293 |
18443751 | Aliskiren--mode of action and preclinical data. | 2008 Jun |
1 |
| 294 |
18465684 | [Aliskiren hemifumarate]. | 2008 Jun |
2 |
| 295 |
18488862 | [Is there a need for direct renin inhibitors?]. | 2008 Mar |
1 |
| 296 |
18490495 | Effects of aliskiren, a direct Renin inhibitor, on cardiac repolarization and conduction in healthy subjects. | 2008 Jul |
1 |
| 297 |
18516803 | Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy. | 2008 Apr |
2 |
| 298 |
18538111 | A study of dose-proportionality in the pharmacokinetics of the oral direct renin inhibitor aliskiren in healthy subjects. | 2008 May |
2 |
| 299 |
18559696 | Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. | 2008 Jun 24 |
4 |
| 300 |
18611061 | Clinical pharmacokinetics and pharmacodynamics of aliskiren. | 2008 |
7 |